http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3434786-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0085
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77ec321af6fca5d98b0fde26eff7063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a083293f6ceffe191679247721d90e9
publicationDate 2019-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3434786-A1
titleOfInvention Method for preparation and anti-counterfeiting authenticating a medical device by the use of a nucleic acid with known partial sequence
abstract The invention relates to a method for the production and forgery-proof authentication of medical devices by using a nucleic acid having a known partial sequence, the method having the following steps:n(i) producing a medical device (MED) with a permanent marker (PM), wherein the medical device (MED) comprises a polymer (P) with the permanent marker (PM) and the permanent marker (PM) at least one nucleic acid (NUK) with a known partial sequence (TSEQ) contains;n(ii) isolating the permanent label (PM); andn(iii) Authentication of the medical device (MED) by detection of the at least one known partial sequence (TSEQ).
priorityDate 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016149296-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009075261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004191801-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016016335-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3085306-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID381514946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137439764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539

Total number of triples: 30.